Oncologix Tech Inc.

CIK 0000799694

Analytics Research this company

Financial snapshot

Revenue

Net income

Operating margin

Free cash flow

Total debt

Cash

Research

Filings

Open the filing explorer →

Recent filings load as you scroll to this section.

Analytical signals

How signals work →

Calculations over this company’s filings, each compared with a stated threshold. They indicate where to read more closely; they are analytical evidence, not conclusions, and none implies wrongdoing.

Earnings quality

P-01 · Calculated

Threshold met

FY 2014-08-31

How reported earnings relate to accruals and to changes in receivables, margins and asset quality.

Beneish M-Score 10.14 is above the -1.78 cut-off used in the original study

Trend: flat

P-01 inputs
Input	Value
model score (0–100)	100.0
m_score	10.139
threshold	-1.78
ratios.DSRI	1
ratios.GMI	1.19
ratios.AQI	0.998
ratios.SGI	15.056
ratios.DEPI	1
ratios.SGAI	1
ratios.LVGI	1.447
ratios.TATA	0.027
defaulted_to_neutral	DSRI, DEPI, SGAI
sloan_accruals	-0.3272
inputs.revenue_t	3677475
inputs.revenue_t1	244246
inputs.total_assets_t	2135458
inputs.net_income_t	-1312043
inputs.cfo_t	-629942
stale	false
latest_filing_period	2014-08-31

Trend

10-K· 2014-12-15 Methodology

Restatement indicators

P-12 · Calculated

Threshold met

FY 2014-08-31

How closely reported accruals and financing patterns resemble those of companies that later restated.

F-Score 20.13 is above the 1.85 reference level of the Dechow et al. model

Trend: flat

P-12 inputs
Input	Value
model score (0–100)	100.0
f_score	20.128
probability	0.07447
components.rsst	-0.3272
components.drec	null
components.dinv	null
components.soft	0.9731
components.dcs	14.0564
components.droa	-0.2931
components.issue	1
model	Dechow et al. 2011, Model 1 (simplified RSST)
thresholds.elevated	1
thresholds.triggered	1.85
stale	false
latest_filing_period	2014-08-31

Trend

10-K· 2014-12-15 Methodology

Interest coverage

P-13 · Calculated

Not comparable

FY 2014-08-31

Interest coverage: not a valid comparison for this company

Calculated, not presented as a result

The calculation is outside what this model can support: interest expense is zero or negative in a year the test counts (net interest income), so interest coverage is not defined for it.

The raw calculation is kept under Details for audit. It is not shown as a level, a score, a ranking or a multiple of a base rate.

Trend: flat

Whether operating earnings cover interest expense, and for how many consecutive years they did not.

P-13 inputs
Input	Value
icr_by_year.2014-08-31	0.71
icr_by_year.2013-08-31	8.384
icr_by_year.2012-08-31	12.186
icr_by_year.2011-08-31	13.364
consecutive_years_below_1	1
altman_z_double_prime	-82.434
definitions.zombie	ICR<1 for 3+ consecutive FYs (BIS 2018)
definitions.z_distress	<1.1 distress, 1.1-2.6 gray, >2.6 safe
inputs.ebit_t	-571839
inputs.interest_expense_t	-805618
stale	false
latest_filing_period	2014-08-31
raw_result.score	37.3
raw_result.level	1
raw_result.headline	Interest coverage 0.71x below 1.0
validity.status	NOT_COMPARABLE
validity.reason	interest expense is zero or negative in a year the test counts (net interest income), so interest coverage is not defined for it

Trend

10-K· 2014-12-15 Methodology

No stored result for Subsidiary jurisdictions, ESG disclosure support, Effective tax rate, Pension funding, Insider filing timing, Language change, Strategic-review language, Carbon-exposed assets. Some signals are computed on request, and others need inputs this company’s filings do not tag; a missing result is not a finding either way.

Methodology and sources

Financial figures come from SEC XBRL company facts (annual reports). Choose any evidence marker to see the filing behind a value.
Filing text comes from SEC EDGAR. Browse this company on EDGAR ↗
Signals are calculated by Stratum from those filings. Some use AI to read filing text, and every AI claim must quote the document verbatim or it is discarded. Full methodology

More tools: chat with the 10-K · generate an investigation memo